Bradley Radoff and Jumana Capital have formed a 7.6% position in Genesco Inc., the Nashville-based footwear and apparel operator, according to a 13D filing that landed this week. The stake marks Radoff's return to public-company activism after a quiet eighteen months and positions Jumana Capital, the Miami-based fund that typically runs concentrated portfolios of 8-12 positions, in a consumer retail name trading at 0.4x sales despite operational momentum.

Genesco operates 1,425 stores across Journeys, Journeys Kidz, Little Burgundy, and Johnston & Murphy, generating $2.3 billion in trailing revenue. The company has posted 19 consecutive quarters of positive comparable-store sales, a streak that started in fiscal Q2 2020 and continued through the most recent quarter ended November 2024. Despite this operational consistency, shares trade at $28, down 22% from the January 2024 high of $36, giving the company an enterprise value of roughly $820 million including net debt of approximately $90 million. The disconnect between operational execution and valuation creates the wedge activists exploit.

Radoff's history is relevant. He spent six years at Engaged Capital before launching his own vehicle in 2019, and his prior campaigns have favored portfolio rationalization over headline-grabbing board fights. Jumana Capital, led by principals with Och-Ziff and Paulson backgrounds, tends to push for asset monetization or strategic consolidation rather than operational micromanagement. The combination suggests the group will press for one of three outcomes: a sale process, a spin-off of the higher-margin Johnston & Murphy dress-shoe business, or aggressive buybacks funded by sale-leaseback transactions on owned real estate. Genesco owns outright 47 store locations and could monetize these properties at cap rates between 6.5%-7.5%, unlocking $60-80 million in liquidity without touching operations.

The activist filing comes as footwear retail consolidation accelerates. Foot Locker acquired atmos and WSS in the past 24 months. Genesco itself divested Lids in 2019 for $100 million and Schuh in 2022 for $72 million, narrowing focus but also shrinking the platform. Strategic buyers—Caleres, VF Corporation, or private equity shops like Sycamore Partners—could justify paying 1.0-1.2x sales for Genesco's brand portfolio, implying a $2.3-2.8 billion enterprise value or $70-90 per share. The math becomes compelling when compared to the current $28 quote.

Allocators should track three specific events. First, Genesco's fiscal Q4 earnings call, scheduled for late March 2025, where management will either acknowledge activist engagement or maintain silence—silence typically signals ongoing private negotiation. Second, any amendment to the 13D filing within 60 days, which would indicate expanded group membership or a shift from passive to active positioning. Third, proxy filings due by late April 2025 for the annual meeting, where board composition changes or shareholder proposals will surface. If Radoff and Jumana push for committee seats rather than full board control, expect a negotiated outcome by mid-Q2.

The footwear sector has seen $4.2 billion in M&A over the past 18 months, and Genesco's enterprise value positions it as digestible for both strategic and financial buyers. The activists now hold enough stock to force a conversation, and the company's board will need to articulate why standalone execution justifies the current discount—or begin the process that doesn't.